Amphastar Pharmaceuticals AMPH Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's other income (expense)?
- Amphastar Pharmaceuticals (AMPH) reported other income (expense) of -$3.58M in Q1 2026.
- How has Amphastar Pharmaceuticals's other income (expense) changed year-over-year?
- Amphastar Pharmaceuticals's other income (expense) increased by 44.4% year-over-year, from -$6.43M to -$3.58M.
- What is the long-term trend for Amphastar Pharmaceuticals's other income (expense)?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's other income (expense) has grown at a 4.2% compound annual growth rate (CAGR), from $14.25M to -$16.78M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.